This HTML5 document contains 50 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n16http://linked.opendata.cz/resource/drugbank/drug/DB01694/identifier/chemspider/
n15http://linked.opendata.cz/resource/drugbank/drug/DB01694/identifier/chebi/
n6http://linked.opendata.cz/resource/drugbank/drug/DB01694/identifier/wikipedia/
n11http://linked.opendata.cz/resource/drugbank/drug/DB01694/identifier/pdb/
n9http://bio2rdf.org/drugbank:
n14http://linked.opendata.cz/resource/drugbank/drug/DB01694/identifier/kegg-compound/
n12http://linked.opendata.cz/resource/drugbank/drug/DB01694/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n8http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n10http://linked.opendata.cz/resource/drugbank/drug/DB01694/identifier/pubchem-substance/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n13http://linked.opendata.cz/resource/drugbank/drug/DB01694/identifier/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB01694
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n8:DB01694 n9:DB01694
dcterms:title
D-tartaric acid
adms:identifier
n6:Tartaric_acid n10:46508249 n11:TAR n12:447315 n13:DB01694 n14:C02107 n15:15672 n16:852
n3:synonym
(2S,3S)-Tartaric acid (-)-Tartaric acid Levotartaric Acid (S,S)-Tartaric acid D-Tartrate (S,S)-Tartrate D-threaric acid
n3:synthesisReference
Eiji Sato, Akira Yanai, "Method for preparing d-tartaric acid." U.S. Patent US3957579, issued February, 1961.
n3:IUPAC-Name
n4:271B6496-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B649C-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B649B-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B6498-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B6499-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B649A-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B64AC-363D-11E5-9242-09173F13E4C5 n4:271B6494-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B6495-363D-11E5-9242-09173F13E4C5 n4:271B6492-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B6493-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B64A2-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B64A3-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B649D-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B649E-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B64A0-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B649F-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B64A1-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
147-71-7
n3:Bioavailability
n4:271B64A8-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B64AA-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B64AB-363D-11E5-9242-09173F13E4C5
n3:Melting-Point
n4:271B64AD-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B64A7-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B64A6-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B64A9-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B6497-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B64A4-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B64A5-363D-11E5-9242-09173F13E4C5